share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director NARAYEN SHANTANU

SEC announcement ·  Apr 1 13:36
Summary by Moomoo AI
Shantanu Narayen, a reporting person for Pfizer Inc [PFE], was involved in a transaction on 03/28/2024. The specific details of the transaction, such as the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholdings, were not disclosed in the announcement. As such, the total value of the shares after the action remains unknown. This information is critical for investors who track insider activities as indicators of a company's financial health and future performance.
Shantanu Narayen, a reporting person for Pfizer Inc [PFE], was involved in a transaction on 03/28/2024. The specific details of the transaction, such as the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholdings, were not disclosed in the announcement. As such, the total value of the shares after the action remains unknown. This information is critical for investors who track insider activities as indicators of a company's financial health and future performance.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more